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Ohshima Island, a small island located 120 km away from the center of
Tokyo, Japan, and sex- and age- matched patients in an urban area in
Tokyo. Assessment scales included the Resilience Scale (RS), EuroQol
and Positive and Negative Syndrome Scale. Levels of salivary alpha-
amylase (SAA) and plasma brain-derived neurotrophic factor (BDNF)
were also examined, together with multiple demographic variables.
Values of interest were compared using independent t-test or chi-
squared test. Multiple linear regression analysis was performed to
identify factors that were associated with RS total scores in the whole
sample (N= 80); the following factors were included as independent
variables: location of residence (Ohshima Island or urban area), sex,
age (o50 years or ≥ 50), duration of illness, EQ-5D VAS score, use of
social resources, history of low birth weight (o2500 g), GAF score,
PANSS total score and biomarkers (i.e. SAA and plasma BDNF levels). A
P-value of o0.05 was considered statistically signiﬁcant (two-tailed).
Results: Eighty subjects were included (40 each in two areas). No
signiﬁcant difference was found in the RS scores between the two
groups (mean± S.D., 103.9 ± 26.1 in Ohshima Island versus 109.4 ± 22.3
in the urban area, P=0.32). There were signiﬁcant differences in some
of the characteristics between the two groups: higher BMI score, more
siblings, less frequency of low birth weight, fewer previous
hospitalizations, more frequent use of anticholinergic drugs, less use
of social resources and lower plasma BDNF level on Ohshima Island as
compared with the urban Tokyo sample. The linear regression analysis
revealed that a longer duration of illness and a higher EQ-5D VAS
score were signiﬁcantly associated with a greater RS total score
(P= 0.037 and P=0.016, respectively) whereas biological data or the
other factors including illness severity did not exhibit any signiﬁcant
relationships with resilience levels.
Discussion: Patients with schizophrenia living on a remote island and
in urban area showed comparable degrees of resilience despite the
difference in geographical location. Although resilience levels are
known to be inﬂuenced by various environmental factors, those
factors in the two groups, both of which are parts of Tokyo
Metropolitan City, may have no essential differences. Moreover, even
if the surrounding environment and cultural background are different,
a similarity in illness severity and social functioning in the two groups
may be a basis for similar resilience levels. On the other hand, a
signiﬁcant correlation was found between a longer duration of illness
and greater resilience levels, which is a novel ﬁnding to the best of our
knowledge. Illness duration and subjective quality of life may be more
pertinent than urbanicity of residential area in determining resilience
levels. Namely, greater resilience among people with a longer
duration of illness may represent their successful psychological
coping and adaptation.
T137. Socio demographic and clinical characteristics in ﬁrst
episode psychosis
Ahmet Ayer*1, Esra Aydinli2, Koksal Alptekin3
1Manisa Mental Health Hospital; 2Dokuz Eylul University; 3Dokuz Eylül Universitesi
Tip Fakultesi Department of Psychiatry
Background: In this study the relation between socio-demographic
variables, alcohol and substance use, the environmental factors such
as traumatic life events and psychotic symptoms in the ﬁrst episode
psychosis patients were examined.
Methods: The study sample consisted of 60 First Episode Psychosis
patients and 60 healthy control subjects. Psychosocial risk factors were
assessed using Social Environment Measurement Tool, Life Events
Scale, Tobacco Alcohol Use Scale and Substance/Marijuana Use Scale.
In addition to the clinical evaluation of the patient group PANSS, the
Young Mania Symptoms Scale and Insight Scale were used for
detecting psychiatric symptoms.
Results: We found statistically signiﬁcant differences regarding the last
year life events, birth season, obsessive compulsive symptoms, familial
liability of schizophrenia and psychosis in 1st degree relatives, and
attempted suicide in patients with ﬁrst psychotic episode compared
to healthy controls.
Discussion: Family liability and substance use were signiﬁcant risk
factors related to psychotic symptoms in patients with ﬁrst episode
psychosis.
T138. Schizophrenia-spectrum disorders and violent
reoffending: a national cohort study of convicted prisoners
Seena Fazel*1, Zheng Chang2, Henrik Larsson2, Paul Lichtenstein2
1University of Oxford; 2Karolinska Institute
Background: There are more than 10 million currently imprisoned, of
which around 4% have schizophrenia-spectrum disorders according
to systematic reviews. In the US and UK, over one-third of released
prisoners are reconvicted for a new crime within 2 years. Evidence on
whether schizophrenia-spectrum disorders increase the risk of
reoffending is inconsistent. With large numbers of individuals with
psychotic disorders in jails and prisons, clariﬁcation of this association
is important to inform mental health services in criminal justice and on
release from custody.
Methods: We undertook a longitudinal cohort study of 47 326
prisoners who have been imprisoned since January 1, 2000 and
released before December 31, 2009 in Sweden. Data on diagnosed
psychiatric disorders were obtained from both inpatient and out-
patient registers. Socio-demographic and criminological factors were
obtained from other population-based registers. Hazard ratios (HRs)
for violent reoffending were calculated by Cox regression.
Results: 1237 (3%) of the men 130 (4%) of women had schizophrenia-
spectrum disorders. A signiﬁcantly increased hazard was also found
for male prisoners with schizophrenia-spectrum disorders after
adjustment for socio-demographic and criminological factors
(adjusted HR= 1·20 (1·09-1·33), but not in the women (HR = 0·74
[0·45-1·20]). Comorbid substance use disorders increased these
hazards (Adjusted HR in the men= 2·68 [2·41-2·98]).
Discussion: Contrary to expert opinion and previous research, we
found that schizophrenia-spectrum disorders are independent risk
factors for violent reoffending in male prisoners. National violence
prevention strategies should consider the role of prison psychiatry.
T139. Predicting clinical outcomes in psychotic disorders using
electronic case registers and natural language processing
Rashmi Patel*1, Robert Stewart1, Philip McGuire1
1IoPPN, King's College London
Background: It is not possible to reliably predict clinical outcomes in
psychotic disorders. Existing research studies are based on relatively
modest sample sizes and may not be representative of everyday
clinical practice. Clinical information is widely recorded in the form of
electronic health records (EHRs). The majority of useful data are stored
in unstructured free text entries. However, the large volume of free
text means that it is not feasible to manually read through records to
identify data of interest. Automated information extraction methods
such as natural language processing (NLP) offer the opportunity to
quickly extract and analyse large volumes of meaningful data from
free text EHRs. I present a summary of three studies using this
approach to investigate clinical outcomes in people with
schizophrenia.
Methods: Dataset: South London and Maudsley NHS Trust (SLaM)
Biomedical Research Centre (BRC) Case Register comprising anon-
ymised EHRs of over 250,000 people. NLP development: The software
package TextHunter was used. All sentences containing keywords
relevant to the constructs investigated were extracted using a support
vector machine learning (SVM) approach. Predictor variables: pre-
sentation to high-risk clinical services, cannabis use (NLP-derived) and
negative symptoms (NLP-derived). Outcomes: number of days spent
in hospital, frequency of hospital admission and antipsychotic
treatment failure. Covariates: age, gender, ethnicity, marital status
and diagnosis. Statistical analysis: multivariable logistic, negative
binomial, linear regression and mediation analysis using STATA.
Results: (i) Clinical outcomes of FEP in high-risk services (n=2,943): 164
patients with FEP (5.6%) presented to OASIS, a clinical service in South
London for young people with an at-risk-mental-state (ARMS) for
psychosis. Presentation to the high-risk service was associated with 17
fewer days spent in hospital (95% CI -33.7, -0.3) and a lower frequency
of admission (incidence rate ratio: 0.49, 0.39-0.61) in the 24 months
following referral, as compared to patients who presented to
conventional services. (ii) Cannabis and treatment failure in FEP
(n= 2,026): Cannabis use was present in 46.3% of people with FEP. It
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was associated with increased frequency of hospital admission
(incidence rate ratio 1.50, 1.25-1.80) and greater number of days
spent in hospital (B coefﬁcient 35.1 days, 12.1-58.1). An increase in the
number of unique antipsychotics prescribed to cannabis users
mediated an increased frequency of hospital admission (natural
indirect effect: 1.11, 1.04-1.17; total effect: 1.41, 1.22-1.64) and greater
number of days spent in hospital (NIE: 16.1, 6.7-25.5; TE: 19.9, 2.5-37.3).
(iii) Negative symptoms and clinical outcomes in chronic schizo-
phrenia (n=7,678): 55.7% of people with schizophrenia had at least
one negative symptom documented. Negative symptoms were
associated with increased likelihood of hospital admission (odds ratio
1.24, 95% CI 1.10-1.39), re-admission (1.58, 1.28-1.95) and length of
stay (B coefﬁcient 20.5, 7.6-33.5).
Discussion: It was possible to use EHR data extracted using NLP to
investigate associations with clinical outcomes of psychosis in large
sample sizes which would otherwise have been unfeasible to
investigate using direct patient recruitment. These ﬁndings are
important for mental healthcare services as they suggest that early
detection of psychosis in high-risk services may be associated with
better outcomes, and that greater attention should be given to
cannabis use and negative symptoms in people with established
psychotic disorders. The NLP tools developed in these studies also
have the potential to support real-time clinical decision making at an
individual patient level.
T140. A comparative study on the prevalence rate and
treatment of agitation among Chinese newly hospitalized
schizophrenics between psychiatric hospitals and general
hospitals
Hongyan Zhang*1, Suzhen Zhang1, Wifeng MI1, Qi Liu1, Lingzhi Li1
1Peking University Sixth Hospital, Peking University Institute of Mental Health
Background: Agitation is frequently reported with newly hospitalized
patients suffering from schizophrenia, and may result in substantial
adverse outcomes for themselves, others, and property. This study
was designed to investigate the prevalence rate and treatment of
agitation among newly hospitalized schizophrenics between psychia-
tric hospitals and general hospitals.
Methods: We conducted a non-interventional, multicenter, observa-
tional study in 10 psychiatric hospitals and 4 general hospitals.
Information about agitation and treatment of all enrolled patients
were investigated including general demographic data, disease
characteristics, Clinical Global Impression-Severity (CGI-S), Positive
and Negative Syndrome Scale–Excited Component (PANSS-EC),
Modiﬁed Overt Aggression Scale (MOAS) and prescription.
Results: 1.Of 1512 patients enrolled in the study, 1400(92.6%) were
eligible; the prevalence of agitation among psychiatric hospitals was
signiﬁcantly higher than that of general hospitals (64.30% vs. 52.8%,
P□0.01□. 2. The general hospitals had higher proportion of oral
medication□P□0.05□, whereas the psychiatric hospitals had higher
proportion of intramuscular medication□P□0.01□and a combination
of oral medication with intramuscular medication□P□0.01□. Oral
medication most frequently prescribed was olanzapine□32.24%□,
subsequently were risperidone□30.25%□, subsequently were cloza-
pine□12.90%□; intramuscular medication most frequently prescribed
was haloperidol□35.40%□, subsequently were ziprasidone□9.61%□,
subsequently were benzodiazepines□4.69%□. The general hospitals
had more than double use frequency of clozapine than the psychiatric
hospitals□P□0.01□. With respect to ziprasidone intramuscu-
lar,12.5%□82□of patients from psychiatric hospital had ziprasidone
intramuscular, while none of the patients from psychiatric hospital did.
No statistical difference were found in oral risperidone□P□0.05□and
haloperidol intramuscular□P□0.05□between the psychiatric hospitals
and general hospitals.
Discussion: Our study indicated that, in China, the prevalence of
agitation among psychiatric hospitals was signiﬁcantly higher than
that of general hospitals (64.30% vs. 52.8%, P□0.01□. In addition,
patients in the psychiatric hospitals experienced a signiﬁcantly older
age, longer illness duration, more numbers of hospitalizations and
higher CGI score, higher proportion of history of aggressive behaviors
and involuntary admission than the general hospitals. These ﬁndings
suggest that the psychiatric hospital group were more likely to be in
more complex situations, higher risk of uncooperativeness and
refractory schizophrenia, which may contributing to the different
treatment. For the agitation sample, the psychiatric hospitals were
more inclined to use intramuscular medication in managing this
condition with schizophrenia, mainly haloperidol and ziprasidone.
While no one used ziprasidone intramuscular in general hospital,
considering the high price, uneven availability and deﬁcient clinical
practice play a role. As to clozapine, the use frequency in psychiatric
hospitals and general hospitals was 9.8% and 23.4% respectively. Over
the last decade, there was a falling trend in using frequency of
clozapine in China. Since its unique advantages in psychiatric illness, it
is signiﬁcant to avoid the low utilization of clozapine and improve the
rational use in the indication.
T141. The Gothenburg research and investigation on psychosis -
grip: outcomes from a standardized clinical protocol for
psychotic patients
Anneli Goulding*1, Kristina Annerbrink2, David Berg3, Mikael Landén2
1University of Gothenburg; 2Centre for Psychiatry, Sahlgrenska Academy, University
of Gothenburg; 3Sahlgrenska University Hospital
Background: Patients with schizophrenia-spectrum disorders often
have other mental and physical health problems. This complexity
poses challenges for clinicians to make correct judgements regarding
diagnosis and treatment. A standardized clinical protocol was
developed in order to improve diagnostics and provide the most
adequate support for patients who are referred to the Department of
Psychotic Disorders at Sahlgrenska University Hospital in Gothenburg,
Sweden. The Department of Psychotic Disorders serves roughly 3000
patients. The standardized protocol consists of a somatic examination
that includes health blood tests, a spinal tap, magnetic resonance
imaging, and a neurological examination. Further, the protocol
includes structured and semi-structured interviews with patients and
family members that cover family and patient history, substance
habits, and psychiatric symptoms. Moreover, screening instruments
for general psychiatric symptoms, psychosis symptoms, and neurop-
sychiatric symptoms are used. Finally, neuropsychological, physical,
and social functioning is also evaluated. All patients who are referred
to the Department are offered an investigation according to the
clinical protocol and can decline if they wish. The patients who agree
to take part in the clinical investigation are also asked to participate in
a research project (GRIP) attached to the clinical investigation. If they
choose to give written informed consent, all data collected with the
standardized clinical protocol can be coded and used for research
purposes. The only difference between the patients who participate in
GRIP and those who do not is that the blood and liquor from research
subjects is stored for future use (including genetic analyses). All
patients receive regular and structured follow-ups. One major aim of
the GRIP study is to improve diagnostics by grouping subjects
regarding symptom proﬁles, i.e. subgroups with similar phenotypes. It
is possible to combine structured clinical information with genetics,
neuroimaging, and liquor analyses to this end. The aim of the present
study is to describe the group of research participants regarding the
variables included in the clinical protocol.
Methods: The GRIP study has been approved by the Swedish Ethics
Committee. The study design is naturalistic. The study is built into the
ordinary clinical practice. All subjects who give written consent are
included regardless of working diagnosis. No interventions are
suggested. The instruments used to collect data include the PANSS
and M.I.N.I. for psychosis and general psychiatric symptoms, the
RAADS-R, ASSQ, and BAARS-IV for neuropsychiatric symptoms, the
RAND36 for general health, the AUDIT and DUDIT for alcohol and
substance habits, the WAIS-IV, TMT, and Tower of London for
neuropsychological functioning.
Results: To date, 45 patients have been asked to participate in GRIP, 38
have given written informed consent, and three have withdrawn their
consent. Of the 35 participants, 13 were women and 22 were men.
The mean age was 36.5 years (SD= 10.3). Eighteen participants have
agreed to a spinal tap whereas eight have declined. We are in the
process of analyzing the ﬁrst results from the GRIP study and will
present clinically relevant results from spinal taps, MRI, and health
blood samples. We will also describe the symptom proﬁles of the
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